SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000009
Filing Date
2024-06-10
Accepted
2024-06-10 16:05:43
Documents
3
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718049932.html 4  
1 FORM 4 wk-form4_1718049932.xml 4 6683
2 EX-24 poasection16filings-paya.htm EX-24 4129
3 GRAPHIC poasection16filings-paya001.jpg GRAPHIC 249775
  Complete submission text file 0001649094-24-000009.txt   356503
Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Paya Carlos V (Reporting) CIK: 0001606244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241032688

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)